Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future
Rui-Kyi Ng, Vishal G Shelat · 2026
Read Carbohydrate antigen 72-4 and tumor-associated glycoprotein 72 - tumor marker: Past, present and future by Rui-Kyi Ng, Vishal G Shelat (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13598452.txt.
Description
Rui-Kyi Ng and Vishal Shelat review a blood tumor marker and the protein it tracks in a 2026 paper. The marker, CA72-4, was found in the era of lab made antibodies and is tied most closely to stomach cancer. Interest in it has since spread across gut cancers, belly disease, and fluid tests. The review covers its history, biology, clinical use, and limits, with stomach cancer as the main anchor.
Current evidence casts the marker as a helper, not a screening test or a stand alone diagnosis. Its strongest roles are sorting risk in stomach cancer, judging disease spread in the belly, adding to multi marker panels, and working up suspicious fluid build up. The tracked protein itself may end up mattering more than the blood test, the authors argue. That would follow if imaging, cell based tests, and targeted treatments built on it keep maturing.
Catalog record
| CREATOR | Rui-Kyi Ng, Vishal G Shelat |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |